NCT01316250 2025-10-02
Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
American University of Beirut Medical Center
Phase NA Completed
American University of Beirut Medical Center
Vastra Gotaland Region
Shanghai Zhongshan Hospital
Sun Yat-sen University
National Cancer Institute (NCI)
M.D. Anderson Cancer Center